Evofem Biosciences, Inc. (EVFM): Depreciation & Amortization
Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$477.0K
Year ended 2023-12-31
+16.5%
3-year compound annual growth
+12.7%
5-year compound annual growth
+20.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $477.0K | -53.0% | 2024-03-27, From 2023-01-01 |
| 2022-12-31 | $1.01M | -0.8% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $1.02M | +238.7% | 2023-04-27, From 2021-01-01 |
| 2020-12-31 | $302.0K | +14.8% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $263.0K | +0.4% | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | $262.0K | +7.4% | 2020-03-12, From 2018-01-01 |
| 2017-12-31 | $244.0K | +253.1% | 2019-03-01, From 2017-01-01 |
| 2016-12-31 | $69.1K | +18.3% | 2018-02-26, From 2016-01-01 |
| 2015-12-31 | $58.4K | +230.7% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $17.7K | -75.5% | 2017-03-23, From 2014-01-01 |
| 2013-12-31 | $72.2K | n/a | 2016-03-29, From 2013-01-01 |